Abstract
The pharmacokinetics and tissue penetration of four quinolones were studied. The compounds were norfloxacin (400 mg p.o.), enoxacin (600 mg p.o. and 400 mg i.v.), ciprofloxacin (100 mg i.v. and 500 mg p.o.) and ofloxacin (600 mg p.o.) given to healthy volunteers. Of the oral agents studied ofloxacin and ciprofloxacin were the most rapidly absorbed (Tmax 1.2 h) and enoxacin the least (Tmax 1.9 h). The serum levels attained were highest in the case of ofloxacin (after allowing for the higher dose administered). The serum half-lives were norfloxacin 3.75 h, ciprofloxacin 3.9 h (p.o.), 4.0 h (i.v.), ofloxacin 7.0 h and enoxacin 6.2 h (p.o.) and 5.1 h (i.v.). All agents penetrated the blister fluid readily. The 24 h urine recovery (as measured by a microbiological assay) was 62% for enoxacin (p.o.), 46.4% following i.v. enoxacin (plus 11.6% oxo-enoxacin, measured by HPLC) 27% for norfloxacin, 30.6% for oral ciprofloxacin, 75.7% for i.v. ciprofloxacin and 73% for ofloxacin.
MeSH Terms
Adult
Anti-Infective Agents/blood,metabolism,urine
Ciprofloxacin/blood,metabolism,urine
Enoxacin
Half-Life
Humans
Kinetics
Male
Naphthyridines/blood,metabolism,urine
Norfloxacin/blood,metabolism,urine
Ofloxacin
Oxazines/blood,metabolism,urine
Tissue Distribution
Chemicals
Anti-Infective Agents
Naphthyridines
Oxazines
Enoxacin
Ciprofloxacin
Ofloxacin
Norfloxacin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Wise R
Lister D
McNulty C A
Griggs D
Andrews J M
References (13)
13 references, click to expand
-
In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.
J Antimicrob Chemother. 1984 Mar;13(3):237-44
PMID: 6586712
-
The antimicrobial spectrum of norfloxacin.
J Antimicrob Chemother. 1984 May;13 Suppl B:25-31
PMID: 6234272
-
Pharmacokinetics and tissue penetration of ciprofloxacin.
Antimicrob Agents Chemother. 1983 Nov;24(5):784-6
PMID: 6660852
-
In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound.
Antimicrob Agents Chemother. 1983 May;23(5):658-63
PMID: 6223577
-
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.
Antimicrob Agents Chemother. 1983 Apr;23(4):559-64
PMID: 6222695
-
In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
Eur J Clin Microbiol. 1983 Apr;2(2):111-5
PMID: 6222896
-
Pharmacokinetics and tissue penetration of enoxacin.
Antimicrob Agents Chemother. 1984 Jul;26(1):17-9
PMID: 6591851
-
Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans.
Antimicrob Agents Chemother. 1983 Jan;23(1):1-7
PMID: 6219615
-
Pharmacokinetics of intravenously administered ciprofloxacin.
Antimicrob Agents Chemother. 1984 Aug;26(2):208-10
PMID: 6486762
-
In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
Antimicrob Agents Chemother. 1983 Nov;24(5):754-63
PMID: 6229216
-
The pharmacokinetics and tissue penetration of norfloxacin.
J Antimicrob Chemother. 1984 Jan;13(1):87-92
PMID: 6230344
-
In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid.
Antimicrob Agents Chemother. 1983 May;23(5):641-8
PMID: 6575721
-
The pharmacokinetics and tissue penetration of ofloxacin.
J Antimicrob Chemother. 1984 Dec;14(6):647-52
PMID: 6596301